Latest News on CL

Financial News Based On Company


Advertisement
Advertisement

Neville Rodie & Shaw Inc. Increases Stock Position in Colgate-Palmolive Company $CL

https://www.marketbeat.com/instant-alerts/filing-neville-rodie-shaw-inc-increases-stock-position-in-colgate-palmolive-company-cl-2026-10-05/
Neville Rodie & Shaw Inc. significantly increased its stake in Colgate-Palmolive Company, boosting its holdings by 240.2% to 35,720 shares valued at approximately $3.05 million. Despite institutional investors owning a substantial 80.41% of the company, and Colgate-Palmolive reporting strong Q3 earnings with a declared dividend, company insiders recently sold shares worth roughly $16.1 million. Analysts maintain a "Moderate Buy" rating for CL, with an average price target of $98.65.

Ferguson Wellman Capital Management Inc. Acquires 247,112 Shares of Colgate-Palmolive Company $CL

https://www.marketbeat.com/instant-alerts/filing-ferguson-wellman-capital-management-inc-acquires-247112-shares-of-colgate-palmolive-company-cl-2026-10-05/
Ferguson Wellman Capital Management Inc. significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by purchasing 247,112 shares, bringing its total holdings to 250,829 shares valued at $21.4 million. This move comes as Colgate-Palmolive reported strong quarterly earnings, exceeding EPS expectations and showing a 4.9% revenue increase. Despite insider selling, the company maintains a "Moderate Buy" consensus rating from analysts with an average price target higher than its current share price.

Marathon Petroleum stock hits all-time high at 431.23 USD By Investing.com

https://in.investing.com/news/stock-market-news/marathon-petroleum-stock-hits-alltime-high-at-43123-usd-93CH-5618961
Marathon Petroleum Corp (MPC) stock reached an all-time high of $431.23, reflecting a 163% year-to-date return and strong investor confidence. Despite a recent downgrade from Jefferies, UBS reiterated its Buy rating with an increased price target of $450. The company's performance is further supported by rising oil prices due to Middle Eastern tensions and a significant surge in diesel fuel prices.

CL Maintained by Wells Fargo -- Price Target Lowered to $90

https://www.gurufocus.com/news/9109625/cl-maintained-by-wells-fargo-price-target-lowered-to-90
Wells Fargo maintained an "Equal-Weight" rating for Colgate-Palmolive (CL) but lowered its price target from $95.00 to $90.00. Despite a strong GF Score™ of 84/100 and being 10.4% undervalued according to GuruFocus' GF Value™, the company has seen significant insider selling worth $31 million over the last three months, which may concern investors.

Marathon Petroleum stock hits all-time high at 431.23 USD By Investing.com

https://ng.investing.com/news/stock-market-news/marathon-petroleum-stock-hits-alltime-high-at-43123-usd-93CH-2722143
Marathon Petroleum (MPC) stock has reached an all-time high of $431.23, marking a 163% year-to-date return. This surge is attributed to positive investor sentiment, strong financial health, and rising oil prices amidst Middle Eastern tensions. While UBS maintains a "Buy" rating with a $450 price target, Jefferies downgraded the stock to "Hold" due to refining risk-reward dynamics.
Advertisement

Wells Fargo cuts Colgate-Palmolive stock target to USD 90

https://www.ad-hoc-news.de/boerse/news/corporate-news/wells-fargo-cuts-colgate-palmolive-stock-target-to-usd-90/70233942
Wells Fargo has reduced its stock target for Colgate-Palmolive from $95 to $90, while maintaining a "Hold" rating. This cautious stance by Wells Fargo contrasts with the broader analyst consensus of $98.60, even as Colgate-Palmolive reported increased net sales but decreased GAAP earnings per share in Q2 2026. The company recently declared a quarterly dividend of $0.53 per share, payable in November.

Colgate-Palmolive (NYSE:CL) Price Target Cut to $90.00 by Analysts at Wells Fargo & Company

https://www.marketbeat.com/instant-alerts/analyst-colgate-palmolive-nyse-cl-price-target-cut-to-9000-by-analysts-at-wells-fargo-company-2026-10-05/
Wells Fargo & Company has cut its price target for Colgate-Palmolive (NYSE:CL) from $95.00 to $90.00, while maintaining an "equal weight" rating. Despite this reduction, the company still holds a "Moderate Buy" consensus rating from analysts with an average target of $98.65. Colgate-Palmolive recently surpassed quarterly earnings estimates, reporting $0.99 EPS against a $0.95 consensus, with revenue growing 4.9% year-over-year to $5.36 billion.

Wells Fargo Adjusts Price Target on Colgate-Palmolive to $90 From $95, Maintains Equalweight Rating

https://www.marketscreener.com/news/wells-fargo-adjusts-price-target-on-colgate-palmolive-to-90-from-95-maintains-equalweight-rating-ce785ddbd080f121
Wells Fargo has lowered its price target for Colgate-Palmolive (CL) to $90 from $95, while keeping an "Equalweight" rating on the stock. This adjustment reflects a revised outlook from the analyst firm. The article, published on MarketScreener, requires a membership to view its full content.

116,423 Colgate-Palmolive Company $CL Shares Bought by MassMutual Private Wealth & Trust FSB

https://www.marketbeat.com/instant-alerts/filing-116423-colgate-palmolive-company-cl-shares-bought-by-massmutual-private-wealth-trust-fsb-2026-10-05/
MassMutual Private Wealth & Trust FSB significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) during the third quarter, purchasing an additional 116,423 shares and bringing its total holdings to over 121,000 shares valued at $10.35 million. This move comes as Colgate-Palmolive reported strong quarterly earnings, exceeding analyst expectations, and declared a quarterly dividend of $0.53 per share. Analysts generally maintain a "Moderate Buy" rating for CL, with an average price target indicating potential upside from its current trading levels.

Colgate-Palmolive stock shows a 4.9 percent sales gain in Q2 2026

https://www.ad-hoc-news.de/boerse/news/corporate-news/colgate-palmolive-stock-shows-a-4-9-percent-sales-gain-in-q2-2026/70227385
Colgate-Palmolive reported a 4.9 percent year-over-year sales increase to $5.36 billion in Q2 2026, with base business EPS of $0.99, surpassing the $0.95 consensus. Despite this growth and a consistent dividend history, the stock closed at $84.26, 15.2 percent below its 52-week high, and below the average analyst target of $98.94. The company maintains a "Moderate Buy" consensus from analysts, highlighting a mixed but overall positive outlook for investors.
Advertisement

Is Pantene Cream To Mist Launch Require Action From P&G Stock Investors?

https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/is-pantene-cream-to-mist-launch-require-action-from-pg-stock
Procter & Gamble's Pantene brand has launched Cream to Mist, a new leave-in spray co-created with influencer Abbey Yung, designed to offer cream-level nourishment and heat protection. While this launch is directionally helpful for Pantene's Beauty segment, it is unlikely to significantly impact P&G's overall earnings in the short term, given the company's focus on broader product superiority, R&D, and managing cost headwinds. Investors should consider the wider context of P&G's strategy to refresh brands and defend market share through productivity gains and capital returns, rather than focusing on a single product launch.

A director acquires 271 Colgate-Palmolive (CL) shares through an annual retainer deferral.

https://www.stocktitan.net/sec-filings/CL/form-4-colgate-palmolive-co-insider-trading-activity-905af482b630.html
Colgate-Palmolive director John P. Bilbrey acquired 271 common shares of CL on October 1, 2026, at $87.42 per share. This acquisition was a deferral of a portion of his annual cash retainer into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this transaction, Bilbrey directly holds 40,725 shares and indirectly holds 4,719 shares through a trust.

Colgate-Palmolive (CL) director Brian Newman acquires 214 shares through a deferred cash retainer.

https://www.stocktitan.net/sec-filings/CL/form-4-colgate-palmolive-co-insider-trading-activity-8cd035431d87.html
Colgate-Palmolive director Brian Newman acquired 214 shares of common stock on October 1, 2026, at $87.42 per share. This acquisition was part of his annual cash retainer deferred into a stock unit account under the Deferred Compensation Plan for Non-Employee Directors. Following this transaction, Newman directly holds 8,058 shares and indirectly holds 36 shares through a Family Trust.

Truist raises EOG Resources stock price target to $160 on commodity prices

https://ca.investing.com/news/stock-market-news/truist-raises-eog-resources-stock-price-target-to-160-on-commodity-prices-93CH-4864187
Truist Securities has increased its price target for EOG Resources (NYSE:EOG) stock to $160 from $153, maintaining a Hold rating due to an update in commodity prices. The firm anticipates a "down the middle" third quarter operationally for the oil and gas producer, with strong financial performance expected from realization uplift. Despite the raise, the new target is still below the analyst consensus high, though InvestingPro data suggests the stock is currently undervalued.

Colgate-Palmolive stock after-hours at EUR 75.35: plus 0.05 percent versus prior close

https://www.ad-hoc-news.de/boerse/news/nachboerse/colgate-palmolive-stock-after-hours-at-eur-75-35-plus-0-05-percent-versus/70213331
Colgate-Palmolive stock traded after-hours at EUR 75.35, marking a 0.05 percent increase from its prior close. The company also announced a quarterly cash dividend of USD 0.53 per common share, payable on November 13, 2026. Additionally, Colgate-Palmolive highlighted the expansion of its "Bright Smiles, Bright Futures" oral-health program.
Advertisement

Piper Sandler cuts target for Colgate-Palmolive stock to USD 95

https://www.ad-hoc-news.de/boerse/news/corporate-news/piper-sandler-cuts-target-for-colgate-palmolive-stock-to-usd-95/70210895
Piper Sandler has cut its price target for Colgate-Palmolive stock from $98.00 to $95.00 while maintaining an overweight rating. This new target is below the broader analyst consensus of $98.94. Colgate-Palmolive reported a 4.9% increase in second-quarter 2026 net sales and an 8% rise in Base Business earnings per share.

Keurig Dr Pepper names Russ Torres CEO of new Global Coffee Co. ahead of 2027 spin-off

https://pluang.com/en/news-feed/keurig-dr-pepper-tunjuk-russ-torres-ceo-global-coffee-co
Keurig Dr Pepper has appointed Russ Torres as CEO of its new Global Coffee Co., which is scheduled to spin off in early 2027. Torres will oversee the integration of KDP's and JDE Peet's coffee operations. The new company is projected to generate $16 billion in annual revenue and aims to be a focused global coffee powerhouse.

Colgate-Palmolive stock pre-market at EUR 75.09: minus 0.29 percent

https://www.ad-hoc-news.de/boerse/news/vorboerse/colgate-palmolive-stock-pre-market-at-eur-75-09-minus-0-29-percent/70208401
Colgate-Palmolive stock was trading pre-market at EUR 75.09, showing a 0.29 percent decrease compared to the previous day's close. This drop represents a EUR 0.22 decline from EUR 75.31. Additionally, the company announced a quarterly cash dividend of USD 0.53 per common share, payable on November 13, 2026.

Kimberly-Clark Keeps Raising Its Dividend. The Question Is Whether It Is Keeping Up With Your Costs

https://247wallst.com/investing/2026/09/30/kimberly-clark-keeps-raising-its-dividend-the-question-is-whether-it-is-keeping-up-with-your-costs/
Kimberly-Clark has extended its dividend increase streak to 54 years, but the most recent raise to $1.28 per share is the smallest in recent years, coinciding with a 35% drop in free cash flow. This situation, alongside a pending $48.7 billion acquisition of Kenvue, raises concerns for income investors. While competitors like Procter & Gamble and Colgate-Palmolive have seen growing cash flow, Kimberly-Clark's financial health suggests future dividend increases might remain modest to preserve the streak.

Colgate's Innovation and Premiumization Drive: Can Momentum Persist?

https://uk.finance.yahoo.com/news/colgates-innovation-premiumization-drive-momentum-163300691.html
Colgate-Palmolive (CL) is focusing on innovation, premiumization, brand investments, and emerging market expansion to drive growth. The company aims to strengthen its oral-care portfolio with differentiated products and leverage its global brands. While these strategies offer growth avenues, sustaining momentum depends on balancing pricing with volume, successful product launches, and cost management.
Advertisement

CL DCF Analysis: Intrinsic Value $38 vs Price $86

https://www.gurufocus.com/news/9103151/cl-dcf-analysis-intrinsic-value-38-vs-price-86
A DCF analysis of Colgate-Palmolive Co (CL) indicates an intrinsic value of $37.64 (earnings-based) to $51.24 (FCF-based) against a current price of $86.46, suggesting the stock is significantly overvalued. The company's GF Score™ is 85/100, but its low predictability rank of 0/5 stars makes the DCF models less reliable. The GF Value™, however, offers a more optimistic view, indicating undervaluation, while guru and insider activity present mixed signals.

Unilever PLC (UL) Interactive Stock Chart

https://ca.finance.yahoo.com/quote/UL/chart/
This Yahoo Finance page provides an interactive stock chart for Unilever PLC (UL), along with current stock performance, market data, and recent news articles related to the company. It shows Unilever's stock price, market open status, and comparisons with various indicators. The page also features a section for recent news, including articles about Unilever's portfolio adjustments, the McCormick deal, and analyst perspectives.

Colgate-Palmolive Co Lobbying Profile, 2014

https://www.opensecrets.org/federal-lobbying/clients/colgate-palmolive-co?client_id=196970&cycle=2014
This OpenSecrets profile provides an overview of Colgate-Palmolive Co's lobbying activities for the year 2014. It details the total spending, direct lobbying expenditures, and information on hired firms, lobbyists, issues, agencies, and bills related to their lobbying efforts. The data is based on calculations by OpenSecrets using information from the Senate Office of Public Records, with the most recent year's data updated as of July 23, 2026.

3 CPGs discuss automation, sourcing and logistics risks

https://www.supplychaindive.com/news/3-cpgs-discuss-automation-sourcing-and-logistics-risks/831400/
At a recent Barclays conference, Procter & Gamble, Colgate-Palmolive, and Kimberly-Clark discussed their supply chain strategies and challenges. P&G is implementing "maximum automation" through its Supply Chain 3.0 initiative, while Colgate-Palmolive anticipates rising material costs due to oil prices and plans to offset them through pricing and premiumization. Kimberly-Clark expects increased logistics costs due to tight freight markets and a recent distribution center fire, and aims to reduce costs post-acquisition of Kenvue.

Coca-Cola, Colgate-Palmolive Appoint New Customer Leaders Amid Tech and Pricing Shifts

https://consumergoods.com/coca-cola-colgate-palmolive-appoint-new-customer-leaders-amid-tech-and-pricing-shifts
Coca-Cola and Colgate-Palmolive have announced significant leadership changes within their customer and commercial teams to navigate evolving consumer behaviors and pricing strategies. Roberto Mercadé will become Coca-Cola's chief customer and commercial officer, while Mike Pierson has joined Colgate-Palmolive as EVP, customer development for the U.S. market. These new leaders are tasked with leveraging data-driven and tech-enabled practices to drive customer growth, manage price-pack architectures, and optimize trade spend amidst shifting market dynamics.
Advertisement

Expand Energy Corp stock hits 52-week low at 84.42 USD

https://www.investing.com/news/company-news/expand-energy-corp-stock-hits-52week-low-at-8442-usd-93CH-4922875
Expand Energy Corp's stock has reached a 52-week low of $84.42, marking a 19.7% decline over the past year. Despite its current struggles, the stock trades at a low P/E ratio of 7.37 and is considered undervalued by InvestingPro analysis. The company's recent Q2 earnings surpassed profit expectations but missed on revenue, with analysts offering differing price targets due to market challenges and management changes.

Colgate-Palmolive (CL) Dividend Reaffirmed As Fair Value Debate Comes Into Focus

https://simplywall.st/stocks/us/household/nyse-cl/colgate-palmolive/news/colgate-palmolive-cl-dividend-reaffirmed-as-fair-value-debat
Colgate-Palmolive (CL) has reaffirmed its quarterly dividend of US$0.53 per share, extending a payout history dating back to 1895, despite recent dips in its share price. While one valuation narrative suggests CL is fairly valued at $86.48, aligning closely with its current price, another perspective using a discounted cash flow (DCF) model indicates it might be undervalued by 32.5% at an estimated value of $128.18. The article highlights mixed signals regarding its valuation and income appeal, prompting investors to consider both earnings-based and cash flow-based assessments.

Expand Energy Corp stock hits 52-week low at 84.42 USD

https://in.investing.com/news/stock-market-news/expand-energy-corp-stock-hits-52week-low-at-8442-usd-93CH-5611161
Expand Energy Corp's stock has dropped to a 52-week low of 84.42 USD, marking a 19.7% decline over the past year. Despite its undervaluation according to InvestingPro analysis and a perfect Piotroski Score, the company faces industry challenges, evidenced by its Q2 earnings beating profit but missing revenue estimates. Analyst ratings are mixed, and oil price fluctuations due to geopolitical events are adding pressure to energy stocks like Expand Energy.

McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

https://finance.yahoo.com/markets/stocks/articles/mccormick-readies-q3-earnings-expect-115100984.html
McCormick & Company (MKC) is set to report its third-quarter 2026 earnings on October 1st, with analysts expecting a 14.7% increase in revenues to $2 billion, but an 11.8% fall in earnings per share to 75 cents. The company anticipates top-line growth driven by improving trends in its Consumer segment and continued momentum in Flavor Solutions, despite potential pressures from consumer price sensitivity and inflationary costs. McCormick currently holds a Zacks Rank #4 (Sell) and an Earnings ESP of -1.97%, suggesting a lower likelihood of an earnings beat, unlike Philip Morris International, The Coca-Cola Company, and Colgate-Palmolive Company.

McCormick Readies for Q3 Earnings: What to Expect From MKC Stock?

https://www.tradingview.com/news/zacks:f419653ff094b:0-mccormick-readies-for-q3-earnings-what-to-expect-from-mkc-stock/
McCormick & Company (MKC) is set to report its third-quarter 2026 earnings on October 1st, with analysts expecting top-line growth of 14.7% to $2 billion, but an 11.8% decline in earnings per share to 75 cents. Despite anticipated benefits from improved consumer and flavor solutions segments, profitability may be challenged by continued consumer price sensitivity, inflationary pressures, and increased marketing expenses. The Zacks model does not predict an earnings beat for McCormick, which currently holds a Zacks Rank #4 (Sell) and an Earnings ESP of -1.97%.
Advertisement

Procter & Gamble (PG) Stock May Be 24% Undervalued After Q1 Sales Slip

https://simplywall.st/stocks/us/household/nyse-pg/procter-gamble/news/procter-gamble-pg-stock-may-be-24-undervalued-after-q1-sales
Procter & Gamble (PG) stock may be 24% undervalued according to a Discounted Cash Flow (DCF) model, despite a recent 5% year-over-year sales decline in its Indian subsidiary. The DCF model, which projects modest but steady free cash flow growth, suggests an intrinsic value meaningfully above the current share price of $149.03. Market narratives on PG are split, with some viewing it as fairly valued due to brand strength and earnings consistency, while others see it as overvalued based on simulations.

Colgate-Palmolive Company (NYSE:CL) Stock Has Consensus Target Price of $98.94

https://www.marketbeat.com/instant-alerts/consensus-colgate-palmolive-company-nyse-cl-stock-has-consensus-target-price-of-9894-2026-09-29/
Colgate-Palmolive Company (NYSE:CL) has a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $98.94, exceeding its current share price of $86.51. The company recently surpassed quarterly earnings expectations, reporting $0.99 EPS and $5.36 billion in revenue, and declared a quarterly dividend of $0.53 per share. Insider selling by executives was noted, partly due to tax withholding on vested equity awards, while institutional investors have significantly increased their stakes.

Rep. Kevin Hern Sells Shares of Colgate-Palmolive Company (NYSE:CL)

https://www.marketbeat.com/instant-alerts/congress-rep-kevin-hern-sells-shares-of-colgate-palmolive-company-nyse-cl-2026-09-29/
Representative Kevin Hern (Republican-Oklahoma) recently sold between $1,001 and $15,000 worth of Colgate-Palmolive (NYSE: CL) stock on September 2nd through his family trust, as disclosed on September 25th. He also reported selling shares in several other companies earlier in September. Colgate-Palmolive reported strong quarterly earnings, beating estimates with $0.99 EPS and a 4.9% revenue increase to $5.36 billion, and declared a quarterly dividend of $0.53 per share.

Colgate-Palmolive Co Lobbying Profile, 2025

https://www.opensecrets.org/federal-lobbying/clients/colgate-palmolive-co?client_id=196970&cycle=2025
This article provides a lobbying profile for Colgate-Palmolive Co for the year 2025, detailing its federal lobbying activities. As of July 23, 2026, the company has spent $140,000 on direct lobbying efforts. The data is compiled by OpenSecrets, a nonpartisan organization tracking money in U.S. politics.

Colgate-Palmolive stock last trades at USD 86.49 on September 28, 2026

https://www.ad-hoc-news.de/boerse/news/nachboerse/colgate-palmolive-stock-last-trades-at-usd-86-49-on-september-28-2026/70194823
Colgate-Palmolive shares closed at USD 86.49 on the NYSE on September 28, 2026, marking a 0.50 percent increase. The company recently declared a quarterly dividend of USD 0.53 and is reportedly exploring the sale of some mass-market personal-care brands, including Softsoap, Irish Spring, and Speed Stick.
Advertisement

PG's Baby Care Regains China Lead on Premium Innovation Momentum

https://www.tradingview.com/news/zacks:78aed1bb9094b:0-pg-s-baby-care-regains-china-lead-on-premium-innovation-momentum/
Procter & Gamble's Baby Care business in China has regained its lead, driven by premium innovation tailored to local preferences, focusing on product performance and communication. This recovery is significant for PG's broader presence in China, with double-digit organic sales growth in the past six quarters and a 5-point value share gain. The article also touches on the performances of Church & Dwight and Colgate-Palmolive, highlighting their respective growth strategies and market positions.

How Does Ann Tracy Promote Climate Action & Oral Health?

https://sustainabilitymag.com/news/how-does-ann-tracy-promote-climate-action-oral-health
Ann Tracy, Chief Sustainability Officer at Colgate-Palmolive, has been recognized among the top sustainability leaders for her work in guiding the company's 2030 strategy, which focuses on cutting emissions, promoting social impact, and reducing packaging footprint. Under her leadership, Colgate-Palmolive successfully met its 2025 sustainability goals, reaching two billion children and families with oral health initiatives and contributing over US$250m to communities. The company's new 2030 strategy aims for net-zero carbon emissions by 2040, increased oral health education outreach, and a significant reduction in plastic packaging.

Conagra Brands Readies for Q1 Earnings: What to Expect From CAG Stock?

https://www.tradingview.com/news/zacks:663cb54dd094b:0-conagra-brands-readies-for-q1-earnings-what-to-expect-from-cag-stock/
Conagra Brands (CAG) is projected to experience a decline in both top-line and bottom-line figures for its first-quarter fiscal 2027 earnings, with expected revenue of $2.6 billion and earnings per share of 31 cents. This anticipated decline is attributed to soft category trends, the wrap-up of prior pricing actions, and inflationary pressures, despite some potential offsets from productivity efforts and brand support. The company currently holds a Zacks Rank #4 (Sell), suggesting a low probability of an earnings beat based on the current model.

BNP Paribas Adjusts PT on Colgate-Palmolive to $97 From $101, Keeps Outperform Rating

https://www.marketscreener.com/news/bnp-paribas-adjusts-pt-on-colgate-palmolive-to-97-from-101-keeps-outperform-rating-ce785adcdc8bf225
BNP Paribas has adjusted its price target for Colgate-Palmolive (NYSE:CL) to $97 from $101, while maintaining an "Outperform" rating on the stock. This update reflects a revised valuation for the consumer products company. The stock was trading at $86.06 with a slight gain in pre-market on September 25, 2026.

Colgate-Palmolive stock trades at USD 86.06 after dividend update

https://www.ad-hoc-news.de/boerse/news/corporate-news/colgate-palmolive-stock-trades-at-usd-86-06-after-dividend-update/70192063
Colgate-Palmolive stock was trading at USD 86.06 after declaring a quarterly dividend of USD 0.53, payable on November 13, 2026. The company reported Q2 2026 net sales of USD 5.361 billion and a GAAP EPS of USD 0.86, with analysts setting an average price target of USD 98.94 despite challenges in the North American market.
Advertisement

Colgate-Palmolive's 130-year dividend streak fa...

https://pluang.com/en/news-feed/colgate-palmolive-dividen-berkelanjutan-masih-layak-danai
Colgate-Palmolive has maintained a 130-year dividend streak and 63 consecutive years of dividend increases, but its North American business is shrinking. The company faces growth challenges despite strong global market leadership and solid dividend coverage. With a forward P/E of 21, the stock's premium valuation demands close monitoring of North American market stabilization and improved organic growth.

Colgate-Palmolive Has Paid a Dividend Since 1895. Does That Streak Still Deserves Your Money?

https://247wallst.com/investing/2026/09/27/colgate-palmolive-has-paid-a-dividend-since-1895-does-that-streak-still-deserves-your-money/
Colgate-Palmolive boasts an exceptional dividend record, having paid dividends since 1895 and raised them for 63 consecutive years, making it a Dividend King. While its cash flow comfortably covers its payouts, the company faces bifurcated growth with strong performance in Latin America and Asia Pacific but a decline in North America. Despite a solid dividend and global market share, its premium valuation suggests the stock is priced for perfection, and North America's recovery is crucial for future total returns beyond the dividend yield.

Colgate-Palmolive Has Paid a Dividend Since 1895. Does That Streak Still Deserves Your Money?

https://finance.yahoo.com/markets/stocks/articles/colgate-palmolive-paid-dividend-since-120009183.html
Colgate-Palmolive (CL) has an impressive dividend history, paying continuously since 1895 and increasing it for 63 straight years, making it a Dividend King. While its dividend is secure with strong cash flow coverage, the company faces challenges in North America with declining revenue, though Latin America and its global toothpaste share show strength. The stock's current valuation at 21x forward earnings suggests it's priced for perfection, with its future total return largely dependent on a recovery in its North American market.

Gonzalo Canteros-Paz Drives Sustainable Sourcing at Colgate

https://procurementmag.com/news/gonzalo-canteros-paz-drives-sustainable-sourcing-at-colgate
Gonzalo Canteros-Paz, Chief Procurement Officer at Colgate-Palmolive, is recognized for his 30-year career and strong focus on ethical sourcing, ranking eighth in Procurement Magazine's Top 250 Procurement Leaders list. Colgate-Palmolive's responsible sourcing strategy is built on environmental protection, ethical labor, health and safety, and business integrity, with a comprehensive third-party code of conduct and active partnerships for sustainability. The company emphasizes that sustainability and business success are intertwined, fostering collaboration and rigorous assessment programs.

Colgate-Palmolive Company (CL.SW) analyst ratings, estimates and forecasts

https://uk.finance.yahoo.com/quote/CL.SW/analysis/
This article provides analyst ratings, estimates, and forecasts for Colgate-Palmolive Company (CL.SW), including its current stock price, dividend information, and earnings trends. It details revenue and earnings estimates by quarter and year, along with analyst consensus, high, and low projections for sales and EPS. The report also lists growth estimates compared to the S&P 500 and includes related tickers.
Advertisement

Colgate-Palmolive Company (CL.SW) Stock Forum & Discussion - Yahoo Finance

https://ca.finance.yahoo.com/quote/CL.SW/community/
This page provides stock information for Colgate-Palmolive Company (CL.SW) on Yahoo Finance, displaying a delayed quote of 70.69 CHF with no change. It also notes a cash dividend of CHF 0.53 with an ex-date of October 20, 2026. The page appears to be a stock forum or discussion section, although the actual discussion content is not visible.

Unilever PLC (UNA.AS) Stock Price, News, Quote & History

https://ca.finance.yahoo.com/quote/UNA.AS/
This Yahoo Finance page provides comprehensive information on Unilever PLC (UNA.AS) stock, including its current price, historical data, and key financial metrics. It details the company's segments (Beauty & Wellbeing, Personal Care, Home Care, Foods) and brands, offering insights into its market performance, analyst ratings, and financial health. The page serves as a resource for investors looking to research Unilever's stock.

Colgate-Palmolive stock trades below its yearly high after Q2 growth

https://www.ad-hoc-news.de/boerse/news/corporate-news/colgate-palmolive-stock-trades-below-its-yearly-high-after-q2-growth/70182922
Colgate-Palmolive's stock is trading below its 52-week high despite reporting a 4.9% increase in Q2 net sales to $5.361 billion. While operating profit rose and cash flow improved significantly, GAAP diluted EPS decreased by 5% to $0.86, creating a contrast for investors. The company's stock stood at $85.32 on September 24, 2026, which is 14.10% below its yearly high of $99.33.

HSBC raises Chevron stock price target to $250 on oil sensitivity

https://www.investing.com/news/analyst-ratings/hsbc-raises-chevron-stock-price-target-to-250-on-oil-sensitivity-93CH-4916771
HSBC has increased its price target for Chevron Corp. (NYSE:CVX) to $250 from $218, maintaining a Buy rating, due to the company's significant sensitivity to high oil prices. Chevron's upstream focus and liquids content position it to benefit from the current market, despite less upside from strong global gas prices and refining margins. The revised outlook by HSBC reflects substantial increases in Chevron's cash flow from operations forecasts for 2026-2028.

Envestnet Portfolio Solutions Inc. Buys 49,803 Shares of Colgate-Palmolive Company $CL

https://www.marketbeat.com/instant-alerts/filing-envestnet-portfolio-solutions-inc-buys-49803-shares-of-colgate-palmolive-company-cl-2026-09-25/
Envestnet Portfolio Solutions Inc. significantly increased its stake in Colgate-Palmolive Company (NYSE:CL) by 257.3% in the second quarter, acquiring an additional 49,803 shares to bring its total holdings to 69,161 shares valued at approximately $6.34 million. The article also details other institutional investor activity, analyst ratings, Colgate-Palmolive's recent financial performance including exceeding earnings expectations and declaring a quarterly dividend, and insider selling activity.
Advertisement
Advertisement
Advertisement
Advertisement

Sign Up free to view live trades and discussion forum to make more informed financial decisions. No credit card is required for sign up!
View Daily Trades
Join Discussion

Advertisement
Advertisement
Advertisement
Advertisement